Novo Nordisk : NVO

All Novo Nordisk Articles

160 Articles

Joel South | May 7, 2025 at 9:47 AM EDT

Stock Market Live May 7: China Trade Talks Are On, S&P 500 (VOO) Rises

This article will be updated throughout the day, so check back often for more daily updates. U.S. Treasury Secretary Scott…

Joel South | Apr 29, 2025 at 9:58 AM EDT

S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles

Stock markets opened lower on Tuesday, threatening to break the S&P 500’s five-day winning streak, although the market is moving…

Rich Duprey | Apr 25, 2025 at 2:19 PM EDT

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly (NYSE:LLY | LLY Price Prediction) is a pharmaceutical titan with an $815 billion market cap, putting it on…

Joel South | Apr 25, 2025 at 9:44 AM EDT

S&P 500 (VOO) Live: Alphabet Up, Market Down But Improving Already

And we’re off! The stock market opened for trading a bit lower today than it left off last night. But…

Joel South | Apr 21, 2025 at 9:45 AM EDT

Live Market Update: S&P 500 Opens Lower on Political Rumblings in Washington

Stock market indices opened lower Monday after a three-day weekend, over the course of which President Trump criticized, and even…

Rich Duprey | Apr 17, 2025 at 10:08 AM EDT

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

One man’s trash may be another man’s treasure, but dumpster diving when investing carries risks. You have to wade through…

Omor Ibne Ehsan | Apr 3, 2025 at 2:58 PM EDT

3 Rock-Solid Dividend Stocks That Will Grow Passive Income This Year

Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These…

Rich Duprey | Feb 25, 2025 at 12:41 PM EST

HIMS Stock Craters – Is It a Buying Opportunity?

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said…

Rich Duprey | Feb 24, 2025 at 12:36 PM EST

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO | NVO…

Ian Cooper | Feb 21, 2025 at 11:47 AM EST

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is…

Trey Thoelcke | Feb 14, 2025 at 8:45 AM EST

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50…

Joey Frenette | Jan 23, 2025 at 12:01 PM EST

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After…

Omor Ibne Ehsan | Jan 22, 2025 at 11:15 AM EST

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Eli Lilly (NYSE: LLY | LLY Price Prediction) doesn’t really need much of an introduction. It has become a household…

Rich Duprey | Jan 21, 2025 at 3:15 PM EST

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) has been described as the best pure-play stock in artificial intelligence. The market…

Rich Duprey | Jan 15, 2025 at 9:06 AM EST

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly…

1 … 3 4 5 6 7 … 11

Novo Nordisk : NVO

All Novo Nordisk Articles

Stock Market Live May 7: China Trade Talks Are On, S&P 500 (VOO) Rises

S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles

Eli Lilly Will Be the Next $1 Trillion Stock

S&P 500 (VOO) Live: Alphabet Up, Market Down But Improving Already

Live Market Update: S&P 500 Opens Lower on Political Rumblings in Washington

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

3 Rock-Solid Dividend Stocks That Will Grow Passive Income This Year

HIMS Stock Craters – Is It a Buying Opportunity?

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

AbbVie Just Paid Investors: Here’s How Much They Received

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Novo Nordisk : NVO

All Novo Nordisk Articles

Stock Market Live May 7: China Trade Talks Are On, S&P 500 (VOO) Rises

S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles

Eli Lilly Will Be the Next $1 Trillion Stock

S&P 500 (VOO) Live: Alphabet Up, Market Down But Improving Already

Live Market Update: S&P 500 Opens Lower on Political Rumblings in Washington

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

3 Rock-Solid Dividend Stocks That Will Grow Passive Income This Year

HIMS Stock Craters – Is It a Buying Opportunity?

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

AbbVie Just Paid Investors: Here’s How Much They Received

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.